Literature DB >> 31658997

Inflammation Triggers Liver X Receptor-Dependent Lipogenesis.

Sophie R Liebergall1, Jerry Angdisen1, Shun Hang Chan1, YingJu Chang2, Timothy F Osborne2, Alexander F Koeppel3, Stephen D Turner3,4, Ira G Schulman5.   

Abstract

Immune cell function can be modulated by changes in lipid metabolism. Our studies indicate that cholesterol and fatty acid synthesis increases in macrophages between 12 and 18 h after the activation of Toll-like receptors with proinflammatory stimuli and that the upregulation of lipogenesis may contribute to the resolution of inflammation. The inflammation-dependent increase in lipogenesis requires the induction of the liver X receptors, members of the nuclear receptor superfamily of transcription factors, by type I interferons in response to inflammatory signals. Instead of the well-established role for liver X receptors in stimulating cholesterol efflux, we demonstrate that liver X receptors are necessary for the proper resumption of cholesterol synthesis in response to inflammatory signals. Thus, liver X receptors function as bidirectional regulators of cholesterol homeostasis, driving efflux when cholesterol levels are high and facilitating synthesis in response to inflammatory signals. Liver X receptor activity is also required for the proper shutdown of a subset of type I interferon-stimulated genes as inflammation subsides, placing the receptors in a negative-feedback loop that may contribute to the resolution of the inflammatory response.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  inflammation; lipid synthesis; lipids; macrophage; nuclear receptor; transcription; transcriptional regulation

Mesh:

Substances:

Year:  2020        PMID: 31658997      PMCID: PMC6944475          DOI: 10.1128/MCB.00364-19

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma.

Authors:  Serena Ghisletti; Wendy Huang; Sumito Ogawa; Gabriel Pascual; Mu-En Lin; Timothy M Willson; Michael G Rosenfeld; Christopher K Glass
Journal:  Mol Cell       Date:  2007-01-12       Impact factor: 17.970

2.  Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes.

Authors:  Jee Hoon Lee; Sang Myun Park; Ohn Soon Kim; Chang Seok Lee; Joo Hong Woo; Soo Jung Park; Eun-hye Joe; Ilo Jou
Journal:  Mol Cell       Date:  2009-09-24       Impact factor: 17.970

3.  Non-redundant roles for LXRalpha and LXRbeta in atherosclerosis susceptibility in low density lipoprotein receptor knockout mice.

Authors:  Eric D Bischoff; Chris L Daige; Mary Petrowski; Harry Dedman; Jennifer Pattison; Joseph Juliano; Andrew C Li; Ira G Schulman
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

Review 4.  mTOR couples cellular nutrient sensing to organismal metabolic homeostasis.

Authors:  Jessica J Howell; Brendan D Manning
Journal:  Trends Endocrinol Metab       Date:  2011-01-25       Impact factor: 12.015

Review 5.  Omega-3 fatty acids and inflammatory processes: from molecules to man.

Authors:  Philip C Calder
Journal:  Biochem Soc Trans       Date:  2017-09-12       Impact factor: 5.407

6.  Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production.

Authors:  Ashley J Fowler; Mary Y Sheu; Matthias Schmuth; Jack Kao; Joachim W Fluhr; Linda Rhein; Jon L Collins; Timothy M Willson; David J Mangelsdorf; Peter M Elias; Kenneth R Feingold
Journal:  J Invest Dermatol       Date:  2003-02       Impact factor: 8.551

7.  Prevention of atherosclerosis by bioactive palmitoleate through suppression of organelle stress and inflammasome activation.

Authors:  Ismail Çimen; Begüm Kocatürk; Seda Koyuncu; Özlem Tufanlı; Umut I Onat; Asli D Yıldırım; Onur Apaydın; Şeyma Demirsoy; Zaliha G Aykut; Uyen T Nguyen; Steven M Watkins; Gökhan S Hotamışlıgil; Ebru Erbay
Journal:  Sci Transl Med       Date:  2016-09-28       Impact factor: 17.956

8.  Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response.

Authors:  Patricia Pacheco; Adriana Vieira-de-Abreu; Rachel N Gomes; Giselle Barbosa-Lima; Leticia B Wermelinger; Clarissa M Maya-Monteiro; Adriana R Silva; Marcelo T Bozza; Hugo C Castro-Faria-Neto; Christianne Bandeira-Melo; Patricia T Bozza
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

9.  LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling.

Authors:  Ayaka Ito; Cynthia Hong; Xin Rong; Xuewei Zhu; Elizabeth J Tarling; Per Niklas Hedde; Enrico Gratton; John Parks; Peter Tontonoz
Journal:  Elife       Date:  2015-07-14       Impact factor: 8.140

10.  Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon.

Authors:  Andrea Reboldi; Eric V Dang; Jeffrey G McDonald; Guosheng Liang; David W Russell; Jason G Cyster
Journal:  Science       Date:  2014-08-08       Impact factor: 47.728

View more
  5 in total

1.  Cell cycle regulation of ER membrane biogenesis protects against chromosome missegregation.

Authors:  Holly Merta; Jake W Carrasquillo Rodríguez; Maya I Anjur-Dietrich; Tevis Vitale; Mitchell E Granade; Thurl E Harris; Daniel J Needleman; Shirin Bahmanyar
Journal:  Dev Cell       Date:  2021-11-30       Impact factor: 12.270

2.  LXRα Regulates oxLDL-Induced Trained Immunity in Macrophages.

Authors:  Hannes M Findeisen; Vivienne C Voges; Laura C Braun; Jannik Sonnenberg; Dennis Schwarz; Helena Körner; Holger Reinecke; Yahya Sohrabi
Journal:  Int J Mol Sci       Date:  2022-05-31       Impact factor: 6.208

Review 3.  Liver X receptors and liver physiology.

Authors:  Lillian Russo-Savage; Ira G Schulman
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-03-11       Impact factor: 6.633

4.  Monocyte and Macrophage Lipid Accumulation Results in Down-Regulated Type-I Interferon Responses.

Authors:  Lisa Willemsen; Hung-Jen Chen; Cindy P A A van Roomen; Guillermo R Griffith; Ricky Siebeler; Annette E Neele; Jeffrey Kroon; Marten A Hoeksema; Menno P J de Winther
Journal:  Front Cardiovasc Med       Date:  2022-02-10

Review 5.  The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation.

Authors:  Dustin Beyer; Jessica Hoff; Oliver Sommerfeld; Alexander Zipprich; Nikolaus Gaßler; Adrian T Press
Journal:  Mol Med       Date:  2022-07-30       Impact factor: 6.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.